关于甘源食品股份有限公司 募集资金年度存放与使用情况鉴证报告 目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 我们鉴证了后附的甘源食品股份有限公司（以下简称甘源食品公司）管理层 编制的 2024 年度《关于募集资金年度存放与使用情况的专项报告》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供甘源食品公司年度报告披露时使用，不得用作任何其他目的。 我们同意将本鉴证报告作为甘源食品公司年度报告的必备文件，随同其他文件一 起报送并对外披露。 二、管理层的责任 甘源食品公司管理层的责任是提供真实、合法、完整的相关资料，按照《上 市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年 修订）》（证监会公告〔2022〕15 号）和《深圳证券交易所上市公司自律监管 指引第 1 号——主板上市公司规范运作（2023 年 12 月修订）》（深证上〔2023〕 1145 号）的规定编制《关于募集资金年度存放与使用情况的专项报告》，并保 证其内容真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 三、注册会计师的责任 我们的责任是在实施鉴证工作的基础上对甘源食品公司 ...

国信证券股份有限公司关于甘源食品股份有限公司 2024 年度募集资金存放与使用专项核查报告 根据《证券发行上市保荐业务管理办法》《上市公司监管指引第 2 号——上 市公司募集资金管理和使用的监管要求》《深圳证券交易所上市公司自律监管指 引第 1 号——主板上市公司规范运作》等有关规定的要求，国信证券股份有限公 司（以下简称"国信证券"或"保荐机构"）作为甘源食品股份有限公司（以下 简称"甘源食品"或"公司"）首次公开发行股票的保荐机构，对甘源食品 2024 年度募集资金存放与使用情况进行了专项核查，具体情况如下： 一、保荐机构进行的核查工作 国信证券保荐代表人通过与公司董事、监事、高级管理人员、内部审计、注 册会计师等人员交谈，查询了募集资金专户，查阅了内部审计报告、年度募集资 金存放与使用的专项说明、会计师募集资金年度使用情况鉴证报告以及各项业务 和管理规章制度，从公司募集资金的管理、募集资金的用途、募集资金的信息披 露情况等方面对其募集资金制度的完整性、合理性及有效性进行了核查。 二、募集资金基本情况 （一）实际募集资金金额和资金到账时间 经中国证券监督管理委员会证监许可〔2020〕664 号文核准，并经 ...

（独立董事：张锦胜） 作为甘源食品股份有限公司（以下简称"公司"）的独立董 事，2024 年在职期间内，本人严格按照《公司法》《证券法》 《上市公司治理准则》《上市公司独立董事管理办法》《深圳证 券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》及《公司章程》《独立董事工作制度》等有关规定，在工 作中忠实、勤勉、尽责地履行独立董事职责，积极出席公司相关 会议，认真审议董事会各项议案，充分发挥独立董事的作用，切 实维护公司和股东的合法权益，促进公司的规范运作。 现将 2024 年度履行职责的情况述职如下： 一、独立董事的基本情况 张锦胜，男，1971 年 12 月出生，中国国籍，毕业于南昌大 学食品科学与工程专业，博士学位。曾任南昌大学食品学院教师， 南昌赣江生物化工厂研发部工程师，南京东冉医药科技有限公司 法人代表、执行董事，现任南昌大学食品科学与工程教师。2021 年 11 月至今，任公司独立董事。 甘源食品股份有限公司 2024 年度独立董事述职报告 本人具备《上市公司独立董事管理办法》所要求的独立性， 不存在影响独立性的情况。 二、独立董事年度履职概况 （一）出席董事会和股东大会情况 报 ...

甘源食品股份有限公司 章 程 （2025 年 4 月） 1 | 第一章 | 总则 | 3 | | --- | --- | --- | | 第二章 | 经营宗旨和范围 | 4 | | 第三章 | 股份 | 4 | | 第一节 | 股份发行 | 4 | | 第二节 | 股份增减和回购 | 5 | | 第三节 | 股份转让 | 6 | | 第四章 | 股东和股东大会 | 7 | | 第一节 | 股东 | 7 | | 第二节 | 股东大会的一般规定 | 9 | | 第三节 | 股东大会的召集 | 12 | | 第四节 | 股东大会的提案与通知 | 13 | | 第五节 | 股东大会的召开 | 15 | | 第六节 | 股东大会的表决和决议 | 17 | | 第五章 | 董事会 | 21 | | 第一节 | 董事 | 21 | | 第二节 | 董事会 | 23 | | 第六章 | 总经理及其他高级管理人员 | 27 | | 第七章 | 监事会 | 29 | | 第一节 | 监事 | 29 | | 第二节 | 监事会 | 29 | | 第八章 | 财务会计制度、利润分配和审计 | 31 | | 第一节 | 财务会计制度 ...

根据《上市公司独立董事管理办法》《深圳证券交易所 股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等相关规定，甘源食品股 份有限公司（以下简称"公司"）董事会就公司在任独立董 事刘江山先生、张锦胜先生、汤正梅女士的独立性情况进行 评估并出具专项意见如下： 经核查独立董事刘江山先生、张锦胜先生、汤正梅女士 的任职经历以及签署的相关自查报告，公司董事会认为：上 述三位独立董事未在公司担任除独立董事以外的任何职务， 未在公司主要股东公司及其附属企业任职，与公司以及主要 股东之间不存在利害关系或其他可能妨碍其进行独立客观 判断的关系，不存在影响独立董事独立性的情况，符合《上 市公司独立董事管理办法》《深圳证券交易所股票上市规则》 《深圳证券交易所上市公司自律监管指引第 1 号——主板 上市公司规范运作》等法律法规及《公司章程》中对独立董 事独立性的相关要求。 甘源食品股份有限公司 董事会关于独立董事 独立性自查情况的专项报告 董事会 2025 年 4 月 18 日 甘源食品股份有限公司 ...

甘源食品股份有限公司 2024 年度独立董事述职报告 （独立董事：汤正梅） 作为甘源食品股份有限公司（以下简称"公司"）的独立董 事，2024 年在职期间内，本人严格按照《公司法》《证券法》 《上市公司治理准则》《上市公司独立董事管理办法》《深证证 券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》及《公司章程》《独立董事工作制度》等有关规定，在工 作中忠实、勤勉、尽责地履行独立董事职责，积极出席公司相关 会议，认真审议董事会各项议案，充分发挥独立董事的作用，切 实维护公司和股东的合法权益，促进公司的规范运作。 现将 2024 年度履行职责的情况述职如下： 一、独立董事的基本情况 汤正梅，女，1966 年 1 月出生，中国国籍，毕业于江西财 经大学会计专业，本科学历，注册会计师。曾任工商银行萍乡分 行财会部会计、工商银行萍乡分行财会部高级经理，现已退休。 2021 年 11 月至今，任公司独立董事。 本人具备《上市公司独立董事管理办法》所要求的独立性， 不存在影响独立性的情况。 二、独立董事年度履职概况 （一）出席董事会和股东大会情况 报告期内，本人积极参加公司召开的董事会和股东大会，履 行独 ...

作为甘源食品股份有限公司（以下简称"公司"）的独立董 事，2024 年在职期间内，本人严格按照《公司法》《证券法》 《上市公司治理准则》《上市公司独立董事管理办法》《深圳证 券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》及《公司章程》《独立董事工作制度》等有关规定，在工 作中忠实、勤勉、尽责地履行独立董事职责，积极出席公司相关 会议，认真审议董事会各项议案，充分发挥独立董事的作用，切 实维护公司和股东的合法权益，促进公司的规范运作。 现将 2024 年度履行职责的情况述职如下： 一、独立董事的基本情况 刘江山，男，1977 年 7 月出生，中国国籍，北京大学硕士 研究生、对外经济贸易大学博士研究生，法律、翻译硕士、国际 法学专业。曾任北京国闻律师事务所律师，北京功道律师事务所 律师，优选控股有限公司法务总经理，中控国际能源投资有限公 司风控总监，现任北京本慧统道律师事务所律师，北京创羽科技 有限公司法务总经理，萍乡学院知识产权教研室主任、教师。2021 年 11 月至今，任公司独立董事。 二、独立董事年度履职概况 （一）出席董事会和股东大会情况 甘源食品股份有限公司 2024 年度独立董事 ...

| 名称 持有数量(万股) | | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 严斌生 | 1310.67 | 26.38 | 不变 | | 全国社保基金一一七组合 | 110.00 | 2.21 | 30.00 | | 严海雁 | 107.25 | 2.16 | -33.09 | | 华泰证券股份有限公司-中庚价值领航混合型证券投资 基金 | 106.18 | 2.14 | 新进 | | 甘源食品（002991）股份有限公司-2022年员工持股计 | | | | | 划 | 88.68 | 1.78 | -1.08 | | 招商银行股份有限公司-南方阿尔法混合型证券投资基 金 | 85.01 | 1.71 | 新进 | | 广发证券股份有限公司-中庚小盘价值股票型证券投资 基金 | 81.80 | 1.65 | 新进 | | 中国工商银行-汇添富优势精选混合型证券投资基金 | 74.15 | 1.49 | 新进 | | 杭州玖誉资产管理有限公司-玖誉富春先行二号私募证 券投资基金 | 73.68 | 1.48 | -5.46 ...

Financial Performance - The company's operating revenue for 2024 reached ¥2,257,260,993.06, representing a 22.18% increase compared to ¥1,847,559,891.15 in 2023[22]. - The net profit attributable to shareholders for 2024 was ¥376,190,408.71, up 14.32% from ¥329,060,868.83 in 2023[22]. - The net profit after deducting non-recurring gains and losses was ¥341,329,664.24, reflecting a 16.91% increase from ¥291,953,983.85 in 2023[22]. - The basic earnings per share for 2024 was ¥4.14, a 15.64% increase from ¥3.58 in 2023[22]. - The total assets at the end of 2024 amounted to ¥2,270,416,335.74, an 8.37% increase from ¥2,094,996,172.73 at the end of 2023[22]. - The net assets attributable to shareholders at the end of 2024 were ¥1,714,823,885.36, a slight increase of 1.78% from ¥1,684,817,478.25 in 2023[22]. - The cash flow from operating activities for 2024 was ¥327,372,196.07, which is a 26.95% increase compared to ¥257,874,327.34 in 2023[22]. - The weighted average return on equity for 2024 was 21.58%, up from 20.37% in 2023[22]. Revenue Breakdown - The company's total revenue for Q4 was 651,666,904.63 CNY, showing a significant increase compared to Q2's 456,354,847.63 CNY[26]. - The revenue from the distribution model was CNY 1.93 billion, accounting for 85.36% of total revenue, with a growth rate of 22.58%[43]. - The e-commerce model generated CNY 239 million, representing 10.59% of total revenue, with a growth rate of 10.75%[43]. - E-commerce revenue for 2024 was 239,123,314.08 yuan, accounting for 10.59% of total revenue, with a year-on-year growth of 10.75%[59]. Product Development and Innovation - The company is focusing on product innovation and development to meet the increasing consumer demand for quality and health-oriented snacks[36]. - The company launched several new products during the reporting period, including various flavored beans and snacks, enhancing product innovation and differentiation[41]. - The company has over 100 patents, demonstrating a strong commitment to product innovation and development[73]. - The company has successfully developed a new product, BBQ-flavored yellow mung beans, which improves taste, color, and flavor while reducing raw material waste, enhancing overall product efficiency[102]. Market Trends and Strategy - The company operates in the leisure food industry, which is experiencing a growing demand due to rising disposable income and changing consumer preferences[32]. - The market for snack foods is expected to grow, driven by trends towards health, innovation, and brand recognition in the nut and snack categories[35]. - The competitive landscape in the leisure food sector is evolving, with traditional retail channels transforming and new e-commerce platforms gaining prominence[36]. - The company aims to enhance its market position by leveraging emerging sales channels and adapting to consumer trends towards diverse and healthy food options[36]. Cost Management and Financial Health - The company's main business cost for 2024 is approximately ¥1.46 billion, an increase of 23.66% from ¥1.18 billion in 2023[63]. - Direct material costs account for over 77% of the main business costs, with nuts and seeds being the primary raw materials[64]. - The cost of goods sold was ¥1,456,770,389.94, which is a 23.67% increase from ¥1,177,982,215.93 in the previous year[78]. - The gross profit margin for the food industry was 35.46%, slightly down by 0.78% from the previous year[83]. Shareholder and Governance - The company plans to distribute a cash dividend of ¥17.84 per 10 shares, totaling approximately ¥163,000,000 based on 91,609,959 shares[5]. - The company has established a three-year shareholder return plan (2024-2026) to ensure a stable return mechanism for shareholders[196]. - The company held a total of 5 shareholder meetings during the reporting period, ensuring equal treatment of all shareholders, particularly minority investors[154]. - The company maintains independent financial, personnel, and operational structures, ensuring no overlap with controlling shareholders[160]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements and potential risks in its future development outlook[5]. - The company has implemented measures to control risks associated with price fluctuations, liquidity, and policy changes in the futures market[119]. - The company’s hedging activities primarily aim to lock in raw material costs and prevent price volatility risks, achieving the goal of cost stabilization without significant risks[119]. Employee and Talent Management - The total number of employees at the end of the reporting period is 2,808, with 1,723 in the parent company and 1,085 in major subsidiaries[191]. - The company has implemented a comprehensive training program focusing on talent development, quality, safety, and information technology[193]. - The number of R&D personnel increased by 47.80% from 182 in 2023 to 269 in 2024, with the proportion of R&D personnel rising from 7.41% to 9.58%[103]. Future Outlook - The company is focusing on digital transformation to enhance operational efficiency, aiming to build an agile and flexible intelligent manufacturing system and a fully digital operational capability[139]. - The company aims to expand its market share by introducing innovative products that cater to diverse consumer preferences and health trends[101]. - The company anticipates that the overall benefits from the marketing network upgrade will be realized gradually as production capacity increases[128].

Financial Performance - The company's revenue for Q1 2025 was ¥504,037,728.43, a decrease of 13.99% compared to ¥586,039,141.89 in the same period last year[5] - Net profit attributable to shareholders was ¥52,757,916.00, down 42.21% from ¥91,292,733.23 year-on-year[5] - Basic and diluted earnings per share were both ¥0.58, reflecting a decline of 42.00% compared to ¥1.00 in the same period last year[5] - Total operating revenue for the current period was ¥504,037,728.43, a decrease of 14.0% from ¥586,039,141.89 in the previous period[23] - Net profit for the current period was ¥52,767,207.92, a decline of 42.3% compared to ¥91,292,733.23 in the previous period[24] - Earnings per share (EPS) for the current period was ¥0.58, down from ¥1.00 in the previous period[24] Cash Flow - The net cash flow from operating activities decreased by 27.64% to ¥62,698,642.70 from ¥86,653,905.84 in the previous year[5] - Operating cash flow for the current period is ¥62,698,642.70, a decrease of 27.7% compared to ¥86,653,905.84 in the previous period[25] - The net increase in cash and cash equivalents was ¥100,137,500.54, a substantial increase of 1066.83% compared to a decrease of ¥10,357,277.34 in the previous year[14] - Cash and cash equivalents at the end of the period amount to ¥185,617,220.49, compared to ¥235,998,272.62 at the end of the previous period[26] - The net increase in cash and cash equivalents for the current period is ¥100,137,500.54, recovering from a decrease of -¥10,357,277.34 in the previous period[26] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,178,414,563.94, a decrease of 4.05% from ¥2,270,416,335.74 at the end of the previous year[5] - Total current assets decreased from ¥1,247,548,917.49 to ¥1,141,359,788.26, reflecting a decline of approximately 8.5%[20] - Total liabilities decreased to ¥410,823,638.90 from ¥555,592,450.38, a reduction of 26.0%[22] - Total equity attributable to shareholders increased to ¥1,767,581,633.12 from ¥1,714,823,885.36, an increase of 3.1%[22] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,106[16] - The largest shareholder, Yan Binsheng, holds 56.24% of shares, totaling 52,426,980 shares[16] - The number of shares held by the top ten shareholders includes significant stakes from various investment funds, with the top three holding over 63% combined[16] - The total number of shares held by the top ten unrestricted shareholders is 18,000,000 shares, indicating a concentration of ownership[17] Investments and Expenses - The company reported a significant increase in receivables, with notes receivable rising by 618.29% to ¥2,076,828.40 due to the receipt of bank acceptance bills[10] - The net cash flow from investing activities increased by 218.45% to ¥91,608,427.35, primarily due to an increase in recovered time deposits[14] - Research and development expenses remained stable at ¥6,210,591.13, slightly up from ¥6,198,190.03[23] - Cash received from the recovery of investments is ¥375,900,000.00, up from ¥355,021,000.00 in the previous period, reflecting improved investment recovery[25] - Cash paid for the purchase of fixed assets and intangible assets is ¥33,764,476.93, down from ¥63,629,650.80 in the previous period, indicating reduced capital expenditure[25] Other Information - The company has no preferred shareholders or related party transactions reported in the current period[18] - The company has not reported any new product developments or market expansion strategies in the current earnings call[19] - The company has not yet audited the first quarter report for 2025[27] - The company plans to implement new accounting standards starting from 2025[27]